

Dechra Pharmaceuticals Plc
DPH:LNLondon Stock Exchange
Overview
Company Profile
Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.
Classification
SectorHealthcare
ExchangeLondon Stock Exchange
